| ASSET | YEAR | % RETURN |
|---|---|---|
| Cato (CATO) | 1991 | 1,834.15% |
| Envela (ELA) | 1991 | 985.47% |
| Biomerica (BMRA) | 1991 | 897.34% |
| BioLife Solutions (BLFS) | 1991 | 765.98% |
| Magna International (MGA) | 1991 | 610.49% |
| Shyft (SHYF) | 1991 | 591.56% |
| Jack Henry & Associates (JKHY) | 1991 | 572.99% |
| Oppenheimer (OPY) | 1991 | 478.99% |
| International Game Technology (IGT) | 1991 | 441.24% |
| Abeona Therapeutics (ABEO) | 1991 | 433.51% |
| Gencor Industries (GENC) | 1991 | 411.21% |
| Vicor (VICR) | 1991 | 398.56% |
| Heron Therapeuti (HRTX) | 1991 | 394.12% |
| Mesa Laboratories (MLAB) | 1991 | 383.34% |
| CEL-SCI (CVM) | 1991 | 379.07% |
| National HealthCare (NHC) | 1991 | 335.92% |
| Veru (VERU) | 1991 | 325.4% |
| Toll Brothers (TOL) | 1991 | 309.11% |
| STAAR Surgical (STAA) | 1991 | 306.95% |
| Bio-Techne (TECH) | 1991 | 303.96% |
| Electronic Arts (EA) | 1991 | 302.66% |
| Educational Development (EDUC) | 1991 | 299.7% |
| Charles Schwab (SCHW) | 1991 | 295.32% |
| Plexus (PLXS) | 1991 | 289.75% |
| Celldex Therapeutics (CLDX) | 1991 | 282.61% |
